Literature DB >> 32376938

China is promoting coronavirus treatments based on unproven traditional medicines.

David Cyranoski.   

Abstract

Entities:  

Keywords:  Government; Health care; SARS-CoV-2

Year:  2020        PMID： 32376938     DOI： 10.1038/d41586-020-01284-x

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

Review 1.  Supramolecular assemblies based on natural small molecules: Union would be effective.

Authors:  Yong Hou; Linjun Zou; Qinglong Li; Meiying Chen; Haonan Ruan; Zhaocui Sun; Xudong Xu; Junshan Yang; Guoxu Ma
Journal:  Mater Today Bio       Date:  2022-06-15

2.  The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 2 - basic research and education.

Authors:  Sunju Park; Dae-Hyun Hahm; Myungsoo Joo; Kyongmin Kim; Sunoh Kwon; Hoyoung Choi; Hyangsook Lee
Journal:  Integr Med Res       Date:  2020-07-24

3.  Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope.

Authors:  Abhishek Shankar; Anusha Dubey; Deepak Saini; Chandra Prakash Prasad
Journal:  Chin J Integr Med       Date:  2020-08-05       Impact factor: 1.978

4.  Traditional Chinese medicine for combating COVID-19.

Authors:  Kaixian Chen; Hongzhuan Chen
Journal:  Front Med       Date:  2020-07-23       Impact factor: 4.592

Review 5.  COVID-19: From pathogenesis models to the first drug trials.

Authors:  Harald Brüssow
Journal:  Microb Biotechnol       Date:  2020-06-23       Impact factor: 5.813

6.  Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  J Ethnopharmacol       Date:  2021-01-21       Impact factor: 5.195

7.  Intellectual Structure of Coronavirus Research: A Perspective From an Author Cocitation Analysis.

Authors:  Junyi Mei; Dangzhi Zhao; Andreas Strotmann
Journal:  Front Res Metr Anal       Date:  2020-11-10

8.  Comparative retrospective open-label study of ayurvedic medicines and their combination with allopathic drugs on asymptomatic and mildly-symptomatic COVID-19 patients.

Authors:  Acharya Balkrishna; Aarti Ben Bhatt; Pratima Singh; Swati Haldar; Anurag Varshney
Journal:  J Herb Med       Date:  2021-05-21       Impact factor: 3.032

Review 9.  Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19.

Authors:  Zhong Sun; Guozhong He; Ninghao Huang; Karuppiah Thilakavathy; Jonathan Chee Woei Lim; S Suresh Kumar; Chenglong Xiong
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

10.  Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis.

Authors:  Arthur Yin Fan; Sherman Gu; Sarah Faggert Alemi
Journal:  J Integr Med       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.